News
LHDX
--
0.00%
--
73 Biggest Movers From Yesterday
Gainers AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) shares jumped 65.9% to close at $2.77 on Monday after gaining around 10% on Friday.
Benzinga · 5d ago
XERS, AGRX and LHDX among mid-day movers
Gainers: Data Storage Corporation (DTST) +40%. Indonesia Energy Corporation (INDO) +30%. Harpoon Therapeutics (HARP) +28%. Pulse Biosciences (PLSE) +24%. Praxis Precision Medicines (PRAX) +24%. Xeris Biopharma Holdings (XERS) +24%. Griffon
Seekingalpha · 6d ago
41 Stocks Moving In Monday's Mid-Day Session
Gainers Data Storage Corporation (NASDAQ: DTST) shares jumped 51.1% to $3.4750 after the company reported better-than-expected Q1 financial results.
Benzinga · 6d ago
Lucira Health: Q1 Earnings Insights
Lucira Health (NASDAQ:LHDX) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Lucira Health beat estimated earnings by 600.0%, reporting an EPS of $0.4 versus an esti...
Benzinga · 05/12 21:36
BRIEF-Lucira Health Reports Qtrly EPS $0.31
reuters.com · 05/12 21:24
BRIEF-Lucira Health Reports Q1 Revenue Of $90.5 Million
reuters.com · 05/12 21:00
Lucira Health GAAP EPS of $0.31 beats by $0.22, revenue of $90.5M beats by $4.15M
Lucira Health press release (NASDAQ:LHDX): Q1 GAAP EPS of $0.31 beats by $0.22. Revenue of $90.5M (vs. $4.5M last year) beats by $4.15M. Revenue growth was driven by COVID-19 test
Seekingalpha · 05/12 20:57
Lucira Health Q1 Adj. Net Income $16.668M vs Loss $13.599M In Same Qtr. Last Year, Sales $90.50M Beat $85.35M Estimate
Lucira Health (NASDAQ:LHDX) reported quarterly sales of $90.50 million which beat the analyst consensus estimate of $85.35 million by 6.03 percent. This is a 1.90K percent increase over sales of $4.52 million the same
Benzinga · 05/12 20:04
Lucira Health Swings to Q1 Profit as Revenue Surges; Withdraws 2022 Revenue Guidance
MT Newswires · 05/12 16:21
-- Earnings Flash (LHDX) LUCIRA HEALTH Reports Q1 Revenue $90.5M, vs. Street Est of $86.4M
MT Newswires · 05/12 16:08
Biden mourns one million American lives lost to pandemic, orders flags to fly at half-mast to honor the dead
President Joe Biden mourned the one million American lives lost to the pandemic on Thursday, and said flags will be flown at half-staff at the White House and all public buildings, grounds, military posts and naval vessels until sunset on May 16 to honor t...
marketwatch.com · 05/12 14:12
Lucira Health files with FDA for emergency use of at-home COVID-19, flu test
Lucira Health (NASDAQ:LHDX) said it submitted a request to the U.S. Food and Drug Administration for emergency use authorization (EUA) of its COVID-19 & Flu test. The company said the
Seekingalpha · 05/12 12:21
Lucira Health Reports Filed For Authorization Of COVID-19, Flue At-Home Molecular Test
Lucira Health, Inc. ("Lucira Health" or "Lucira") (NASDAQ:LHDX), a medical technology company focused on the development and commercialization of innovative infectious disease tests, announced today
Benzinga · 05/12 11:04
BRIEF-Lucira Files For Authorization Of First-Of-Its-Kind Covid-19 & Flu At-Home Molecular Test
reuters.com · 05/12 11:01
Lucira Files for Authorization of First-of-its-Kind COVID-19 & Flu At-Home Molecular Test
This first ever at-home COVID-19 and flu test is designed to allow individuals to differentiate between the infections and seek appropriate treatment within 30 minutes from homeEMERYVILLE, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Luci...
GlobeNewswire · 05/12 11:00
Lucira Health Seeks FDA Emergency Use Authorization for COVID-19, Flu At-Home Test
MT Newswires · 05/12 10:02
Analysts Are Optimistic We'll See A Profit From Lucira Health, Inc. (NASDAQ:LHDX)
Lucira Health, Inc. ( NASDAQ:LHDX ) is possibly approaching a major achievement in its business, so we would like to...
Simply Wall St. · 05/09 15:34
Lucira gets EU clearance to sell both COVID-19 & flu and COVID-19 molecular tests
Lucira Health (NASDAQ:LHDX) on Monday said both its COVID-19 & flu and COVID-19 molecular tests have been cleared for sale and distribution throughout the European Union. Both tests developed by
Seekingalpha · 05/09 13:01
Lucira Receives CE Mark For Both COVID-19 & Flu And COVID-19 Molecular Tests
Lucira Health, Inc. ("Lucira Health" or "Lucira") (NASDAQ:LHDX), a medical technology company focused on the development and commercialization of innovative infectious disease tests, announced that
Benzinga · 05/09 12:07
Lucira Receives CE Mark for both COVID-19 & Flu and COVID-19 Molecular Tests
Lucira COVID-19 Test Packaging Lucira COVID-19 Test Packaging Lucira COVID-19 & Flu Test Packaging Lucira COVID-19 & Flu Test Packaging EMERYVILLE, Calif., May 09, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health" or "Lucira") (Nasdaq: LHDX), a...
GlobeNewswire · 05/09 12:00
Webull provides a variety of real-time LHDX stock news. You can receive the latest news about Lucira Health, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About LHDX
Lucira Health, Inc. is medical technology company. The Company is focused on the development and commercialization of transformative and infectious disease test kits. The Company has developed a testing platform that produces high-complexity-laboratory-accurate molecular testing in a single-use and test kit that is powered by two AA batteries and fit in the palm of a hand. Its initial focus is within respiratory diseases, starting with COVID-19 and influenza A and B virus indications. It has developed LUCIRA COVID-19 All-In-One Test Kit (COVID-19 test kit), is a single-use, molecular in vitro diagnostic test that has an analytical sensitivity to detect the SARS-CoV-2 virus. The test is authorized for prescription at-home use.